You should not trade this blog as 4 billion years of evolution is against my judgment.  Give a guy a computer and ability to make colorful pictures and graphs and he sure is going to commit a crime against reason. This is a prime example. I used some sources to make educated guesses to the … Continue reading Is Global Demand for $TSLA Cars to Go Down, Radically?

Four billion years of evolution is against my judgment so don't trade on this. Synthetic Placebo Arm and Statistically Significant... Alzheimer’s Disease Neuroimaging Initiative ADNI also was given data on placebo arms by a number of companies in the industry.  This data can be used to create a model of a statistically significant synthetic (virtual) placebo arm. … Continue reading $AVXL Some other musings on CTAD 2019 upcoming presentation. Blarcamesine

Four billion years of evolution is against my judgment so do not trade on it. Data Three main markets for $TSLA are the US, Europe, and China. See the graph for the number of cars sold in these markets per month. Data for China since January 2019 only. Model 3 was introduced in 2018 and … Continue reading $TSLA estimate future sales as defined by extrapolated trends in sales. $TSLAQ

What to Expect at CTAD 2019? We fret that this company has no respect from anybody but we know with all our hearts that this is the drug.  The press taunts us with "next miracle drug soon to help the sick" meantime short-sellers drive the stock price up and down in order to squeeze few … Continue reading Augmented Phase2a Data Validates Blarcamasine as Alzheimer’s Greatest Hope, Even Before Phase 2/3 Results. $AVXL

The picture worth 1000 words. Yours truly is a moron...but I can read text and graphs.  since I have not been trained in spacecraft engineering and have a bachelor degree in mechanical engineering I always reference my old and trusty Ninth Edition of Mark's Standard Handbook for Mechanical Engineers.  So armed with this information I … Continue reading $SpaceX Starship…let me tell you what I see…$TSLAQ beware!

I tried to compare the reported results from Green Valley Pharma drug GV-971.  I did discuss it two posts before.  Any meaningful data was presented in ADAS-Cog 12 improvement of 2.54 over placebo.  This scale is 70 points with the healthy starting at  5 points and the deterioration is monitored by adding 65 more points … Continue reading Comparing and a bit fudging.. Blarcamesine vs GV-971 from China (Green Valley Pharma (Shanghai))

There is a myriad of Alzheimer's drugs.  Each of them has a therapeutic target.  Just a molecule or a receptor.  The question is how far-reaching waves the drug makes in the patient's physiology?  Are they localized like as in the case of Donezepil; just availability of a neurotransmitter at synapses or system-wide? CATD 2019 for … Continue reading Unified Alzheimer’s Theory? $AVXL is doing what no company has ever done. Blarcamesine

So $AVXL slowly but surely prepares the ground for acceptance of Anavex 2-73 as the drug for Alzheimer's.  Yet, as this takes more than just 18 months and our expectations that everybody and their aunt would be buying $AVXL stock are alway premature, we fear that somewhere out of the left-field a wonderdrug would kill our … Continue reading New guy on the block … Oligomannate…off the boat from China. $AVXL